Podcasts about HIV

Endometriosis-associated pain (1:30), HIV-associated complications (3:30), glucagon-like peptide-1 receptor agonists for obesity in adolescents (7:40), discontinuing antihypertensives (12:40), vertebral compression fractures (14:40), and buprenorphine dosage for opioid use disorder (18:30).

On this high-energy Friday episode host Jeff blends faith and fierce political commentary as he covers a rapid-fire set of stories shaping the moment. The program opens with a personal welcome and a short "Word on Word" Bible segment, then quickly pivots into breaking news and reaction: Jeff's thoughts (and a dream) about Don Lemon's arrest and the legal penalties at stake. Major topics include President Trump's recent Davos-related messaging and reposted propaganda clip, plus Trump administration appointments (Colin McDonald named to head the new National Fraud Enforcement division) and federal moves on election integrity. Jeff plays and reacts to audio clips from figures such as Donald Trump and George Papadopoulos, and discusses reports of a purported sweeping, decade-long DOJ/DOJ–FBI–DNI–CIA RICO-style investigation into senior Democrats and media figures, including mention of a Florida grand jury. The episode examines election-related developments: an FBI raid in Fulton County that seized ballots and machines, possible links to Maricopa County actions, allegations of foreign interference (Dominion/Smartmatic, China) and legal strategies (references to Ed Martin, Sidney Powell, the Brunson appeals matter). Jeff outlines scenarios for how these events might upend the midterm calendar or the party system itself. Health and science topics get heavy coverage: a guest clip alleging dramatic increases in military morbidity/mortality from 2020–2021, claims about vaccine safety and composition (graphene oxide, nanoparticles, HIV proteins), assertions about smart dust and 6G, plus a personal note on natural immunity, medicinal mushrooms, and lifestyle suggestions Jeff endorses. International coverage touches on Canada (Carney/Trudeau, snap election concerns), Keir Starmer and the U.K., U.S. posture in the Western Hemisphere (Greenland, Venezuela, Cuba) and geopolitical resource arguments. Financial policy and currency are also highlighted: Jerome Powell's disclosed DOJ inquiry, Trump's selection of Kevin Warsh for the Fed, talk of a digital currency replacement, and comments from Treasury/Scott Besant on gold, the “golden age” narrative, and potential economic transition strategies. The episode also weaves in personal moments — Jeff asking for prayer amid apparent pressure and threats, promotion of a Saturday night prayer meeting and a Sunday Bible study — and closes with exhortations to love God, family and neighbor while staying alert to the fast-moving political landscape. Expect strong opinions, conspiratorial and controversial claims, audio clips from political insiders, and a host who connects political events to spiritual dynamics throughout. Want to Understand and Explain Everything Biblically?  Click Here: Decoding the Power of Three: Understand and Explain Everything or go to www.rightonu.com and click learn more.  Thank you for Listening to Right on Radio. Prayerfully consider supporting Right on Radio. Click Here for all links, Right on Community ROC, Podcast web links, Freebies, Products (healing mushrooms, EMP Protection) Social media, courses and more... https://linktr.ee/RightonRadio Live Right in the Real World! We talk God and Politics, Faith Based Broadcast News, views, Opinions and Attitudes We are Your News Now. Keep the Faith

In this episode of Let's Go Win, JM Ryerson sits down with bestselling author and prosperity teacher Randy Gage for a deep conversation about the one idea that changes everything: your thinking. Randy has spent decades studying prosperity, consciousness, and human behavior, and his perspective is shaped by lived experience. He went from a teenage life of crime and addiction, to losing a business to the IRS, to an HIV positive diagnosis, and then rebuilt a life that now impacts millions. Together, JM and Randy explore how modern media programs fear and scarcity, the difference between victim thinking and prosperity consciousness, and the practical choices that can change the direction of your life. Key Takeaways: How social media and news amplify fear and anxiety The difference between victim thinking and prosperity consciousness Why personal responsibility matters more than talent or opportunity How mentors and turning points can change the course of a life Simple ways to protect your energy and reset your mindset Why health and mindset are the foundation of lasting success How to rewire limiting beliefs and create real freedom This episode is for entrepreneurs, leaders, and anyone who feels stuck, overwhelmed, or ready for more. If you want to think more clearly, take ownership of your future, and build prosperity from the inside out, this conversation will give you both the mindset and the tools to start changing your trajectory today. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them and billing headaches are common. Here's how to overcome those obstacles.Have a question about navigating the health care system? Contact us here.Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

To celebrate 101 episodes, I sit with Leonard H. Calabrese, DO, to discuss his unique career in Rheumatology, spanning immunology, HIV, MECFS, IRES, CNS vasculitis and more. We also discuss how medical history shaped our careers.  ·        Intro 0:12 ·        Welcome Leonard H. Calabrese, DO 3:11 ·        A quick friendship begins over medical history 4:14 ·        How Healio Rheuminations began and where the show is now 5:38 ·        How Dr. Calabrese got interested in medical history 7:11 ·        Serotherapy 10:52 ·        Why patients get certain diseases 12:33 ·        Dr. Calabrese's career trajectory 14:43 ·        One day in 1981… 17:52 ·        A few things happened in the 90's 20:20 ·        Tell us about CNS vasculitis 21:53 ·        Don't be afraid to reinvent yourself 24:30 ·        Checkpoint inhibitors 25:09 ·        How do you keep up? 26:43 ·        Placebo science 28:25 ·        Do you think we'll ever be able to answer where diseases come from? 29:33 ·        Thank you, Dr. Calabrese 31:01 ·        Thanks for listening 31:26 We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum.

Regardless of your specific role in HIV care, you are almost certainly feeling the deeply challenging moment we face as science-respecting, empathetic human beings. But even as the U.S. response to HIV is persistently undermined by our own federal government, many clinical leaders are finding paths forward. This month, we speak with one of them -- longtime physician/researcher/advocate Benjamin Young, M.D., Ph.D. -- about how he contextualizes our current moment, what priorities he's pursuing now, and what advice he has for healthcare providers who are striving to serve their patients, do their jobs, and support their communities.   Support the pod by clicking/tapping over to our online transcript: https://www.thebodypro.com/podcast/hiv/future-hiv-care-benjamin-young-jan-2026    Browse This Week in HIV Research, in which Dr. Young analyzes recently published clinical science: https://www.thebodypro.com/collection/this-week-in-hiv-research    The host and executive producer of this podcast is Myles Helfand; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; and our audio editor is Kim Buikema.

Jonathan Gleason spent ten years writing the ten essays in his debut collection, Field Guide to Falling Ill (Yale UP, 2026). In them, Gleason braids together strands from a variety of sources – from his experience with a potentially-lethal blood clot, to his imprisoned uncle, to his journey to access medication to prevent HIV – to analyze America's healthcare system and the humiliating, confusing, and depersonalizing effects it can often have. The essays approach medicine from a variety of viewpoints, from Jonathan's perspective as a gay man analyzing the development of HIV medications like AZT and Truvada, to his experience as a Spanish language medical interpreter at a free clinic in Iowa City. But each essay also reminds readers of the importance of understanding the history of our healthcare institutions, and the necessity of feeling less alone when confronted by their myriad failures. Lyrical, poignant, and deeply human, Field Guide to Falling Ill is a poetic approach to understanding medicine in America. For more information on Jonathan and his writing, visit: Jonathan's website: here Jonathan's Substack, Histories of Present Illness: here Emily Dufton is the author of Grass Roots: The Rise and Fall and Rise of Marijuana in America (Basic Books, 2017). Her new book, Addiction, Inc.: Medication-Assisted Treatment and America's Forgotten War on Drugs, will be released in April 2026. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

In episode 66 of Going anti-Viral, Dr Nicolas Chomont joins host Dr Michael Saag to provide a preview of the 2026 Conference on Retroviruses and Opportunistic Infections (CROI). Dr Chomont is Chair of the Scientific Program Committee for CROI 2026 and is a Professor in the Department of Microbiology, Infectious Diseases, and Immunology at the Université de Montréal and a researcher at the CHUM Research Centre. Dr Chomont discusses CROI 2026, highlighting its significance in advancing HIV research and treatment. He emphasizes the importance of community engagement, the support for new investigators, and ongoing research for an HIV cure. The discussion provides the overall themes of the abstracts accepted for CROI 2026 as well as the plenary sessions, symposia, and the impact of funding cuts on research and treatment. Dr Chomont expresses optimism about the future of HIV research and the collaborative spirit of the conference.0:00 – Introduction3:19 – Plenary sessions overview5:41 – Interactive symposia and themed discussion sessions8:09 – Themes of the accepted abstracts 11:09 – Support for new researchers15:25 – Research addressing a cure for HIV 18:21 – Community and collaboration at CROI20:55 – Closing remarks Register for virtual or in-person attendance at CROI 2026: https://www.croiconference.org/ __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Jonathan Gleason spent ten years writing the ten essays in his debut collection, Field Guide to Falling Ill (Yale UP, 2026). In them, Gleason braids together strands from a variety of sources – from his experience with a potentially-lethal blood clot, to his imprisoned uncle, to his journey to access medication to prevent HIV – to analyze America's healthcare system and the humiliating, confusing, and depersonalizing effects it can often have. The essays approach medicine from a variety of viewpoints, from Jonathan's perspective as a gay man analyzing the development of HIV medications like AZT and Truvada, to his experience as a Spanish language medical interpreter at a free clinic in Iowa City. But each essay also reminds readers of the importance of understanding the history of our healthcare institutions, and the necessity of feeling less alone when confronted by their myriad failures. Lyrical, poignant, and deeply human, Field Guide to Falling Ill is a poetic approach to understanding medicine in America. For more information on Jonathan and his writing, visit: Jonathan's website: here Jonathan's Substack, Histories of Present Illness: here Emily Dufton is the author of Grass Roots: The Rise and Fall and Rise of Marijuana in America (Basic Books, 2017). Her new book, Addiction, Inc.: Medication-Assisted Treatment and America's Forgotten War on Drugs, will be released in April 2026. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

New CDC surveillance data show encouraging declines in several sexually transmitted infections—but a troubling increase in syphilis among newborns. In this episode, the Director of the Division of STD Prevention at the National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Dr. Bradley Stoner breaks down the key takeaways from the 2024 provisional STI surveillance report, including declines in chlamydia, gonorrhea, and primary and secondary syphilis, alongside the continued rise in congenital syphilis. The conversation explores what's driving progress, the prevention strategies showing impact, and where urgent action is still needed. Dr. Stoner also discusses how states and local health departments can use provisional data to guide interventions, expand screening and treatment, and prepare for improved data access through CDC's new One CDC Data Platform.Supporting Pharmacies as Contraception Access Hubs | ASTHOOrganizational Strategic Planning Guide | ASTHO

Using the narratives of women who use(d) drugs, this account challenges popular understandings of Appalachia spread by such pundits as JD Vance by documenting how women, families, and communities cope with generational systems of oppression. Prescription opioids are associated with rising rates of overdose deaths and hepatitis C and HIV infection in the US, including in rural Central Appalachia. Yet there is a dearth of studies examining rural opioid use. RX Appalachia: Stories of Treatment and Survival in Rural Kentucky (Haymarket, 2020) explores the gendered inequalities that situate women's encounters with substance abuse treatment as well as additional state interventions targeted at women who use drugs in one of the most impoverished regions in the US. Lesly-Marie Buer is a harm reductionist and medical anthropologist in Knoxville, TN. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Using the narratives of women who use(d) drugs, this account challenges popular understandings of Appalachia spread by such pundits as JD Vance by documenting how women, families, and communities cope with generational systems of oppression. Prescription opioids are associated with rising rates of overdose deaths and hepatitis C and HIV infection in the US, including in rural Central Appalachia. Yet there is a dearth of studies examining rural opioid use. RX Appalachia: Stories of Treatment and Survival in Rural Kentucky (Haymarket, 2020) explores the gendered inequalities that situate women's encounters with substance abuse treatment as well as additional state interventions targeted at women who use drugs in one of the most impoverished regions in the US. Lesly-Marie Buer is a harm reductionist and medical anthropologist in Knoxville, TN. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/gender-studies

Using the narratives of women who use(d) drugs, this account challenges popular understandings of Appalachia spread by such pundits as JD Vance by documenting how women, families, and communities cope with generational systems of oppression. Prescription opioids are associated with rising rates of overdose deaths and hepatitis C and HIV infection in the US, including in rural Central Appalachia. Yet there is a dearth of studies examining rural opioid use. RX Appalachia: Stories of Treatment and Survival in Rural Kentucky (Haymarket, 2020) explores the gendered inequalities that situate women's encounters with substance abuse treatment as well as additional state interventions targeted at women who use drugs in one of the most impoverished regions in the US. Lesly-Marie Buer is a harm reductionist and medical anthropologist in Knoxville, TN. Claire Clark is a medical educator, historian of medicine, and associate professor in the University of Kentucky's College of Medicine. She teaches and writes about health behavior in historical context. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/anthropology

Scientists say research into a vaccine for HIV is further along than it's ever been.But Trump administration cuts to scientific research have set that effort back.Including a promising trial for an HIV vaccine in Africa – which was shut down altogether.NPR's Ari Daniel has the story of how researchers there refused to give up.Ari's reporting for this story was supported by a grant from the Pulitzer Center. The Gates Foundation is a financial supporter of NPR. This episode was produced by Mallory Yu and Kira Wakeam.It was edited by Rebecca Davis and Courtney Dorning.Our executive producer is Sami Yenigun. Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

This week, Marianna sits down with John Faragon to talk about managing missed doses of common injectable medications for treating HIV. Learn all about the different medication options and paths to take as an HIV care provider when doses have been missed. --Long-Acting Injectable PrEP: https://nastad.org/sites/default/files/2023-04/LAI-FAQ-Formatted-Updated4.17.23.pdfLenacapavir as HIV PrEP: https://www.cdc.gov/mmwr/volumes/74/wr/pdfs/mm7435-H.pdf--Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=AQX7941)--Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes. --Check out our free online courses: www.necaaetc.org/rise-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=USApple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

Go behind the scenes of one of the most emotional and historic moments in NBA and sports history — when Magic Johnson shocked the world with his 1991 HIV announcement. In this exclusive interview, Lakers legend Michael Cooper reveals what really happened that day. From the tension in the room to the tears no one saw, this is a powerful untold story about brotherhood, fear, and strength. Showtime w/ Coop is Powered by: 

Jess welcomes LOLA ROCKNROLLA, filmmaker of the brand-new documentary THE BIG JOHNSON, exploring the life and eerie death of DEAN JOHNSON: the 6'6", genderf*cky, rollicking rock-star frontman who helped define 1980s–90s East Village nightlife. Topics — the still-unsettled details around Dean's 2007 death, his bands Dean & the Weenies and The Velvet Mafia, being an HIV+ party promoter & more! "The Big Johnson" screens at NYC's Quad Cinema January 23–29, streaming avail in February ⭐ IG: @jessxnyc | @lolarocknrolla13 ⭐ Jess' docu-series on the rise & fall of SoulCycle — Cult of Body & Soul ⭐ Jess' docu-series on the history, mystique & lore of Fire Island — Finding Fire Island  

Dr. Paul Benson is the founder, owner, and Medical Director of Be Well Medical Center in Berkley, Michigan, a family medicine practice established 45 years ago. He is proud to share he was the first LGBTQ physician to open a medical practice in Metro Detroit, creating a safe, affirming space for patients of all backgrounds, especially those too often overlooked or mistreated in healthcare. While he did not set out to become an HIV specialist, the timing of opening his practice in 1980 placed him at the very beginning of the AIDS epidemic, when fear and stigma kept many providers from treating gay men. What began with caring for friends quickly grew into a trusted medical home for LGBTQ patients and a lifelong commitment to HIV medicine and advocacy.In this candid conversation, Dr. Benson and Dr. Joe Kort reflect on the early years of the epidemic, the loneliness many patients endured, and the enormous changes that arrived as treatments evolved and prevention became possible. Dr. Benson explains why HIV care is an intellectual challenge, not just medically, but emotionally and psychologically, because great care requires seeing the whole person, including mental health. They also discuss today's realities. PrEP is highly effective, but many people who could benefit from it still are not using it consistently. Dr. Benson shares optimism about long acting injectable prevention options and the future of cure research, and he gives a clear, reassuring answer to a question Joe hears often. If someone is not having intercourse, do they need PrEP or other HIV prevention medications? His answer is no.The episode also dives into gender affirming care and what responsible, ethical transgender healthcare actually looks like in a primary care setting. Dr. Benson talks about his decades of experience providing hormone therapy, why careful lab monitoring matters, the risks of using higher than recommended dosing, and his measured approach to puberty blockers and surgical interventions for adolescents. He closes with a message he wants every listener to hear. Mental health is a vital part of total healthcare, and patients deserve a strong support team, including providers who collaborate and patients who advocate for themselves, and who cancel appointments when they cannot make them.Listen to this Smart Sex, Smart Love episode as Dr. Joe Kort talks with Dr. Paul Benson about LGBTQ affirming primary care, the evolution of HIV treatment and prevention, the reality behind transgender medicine, and why mental health support belongs in every healthcare plan.Support the show

Jonathan Van Ness is one of the most recognisable and beloved figures in pop culture today - but in this conversation, they open up about the chapters of their life few people truly understand. Jonathan speaks candidly about addiction, relapse, sex addiction, and living with HIV, including the moment they realised contracting HIV ultimately saved their life by forcing them to confront a dangerous relationship with meth. With extraordinary honesty, Jonathan reflects on survival, recovery, shame, joy, and what it really means to heal. We also talk about identity, coming out as non-binary, people-pleasing, impulse behaviour, and why healing isn’t a destination — it’s a lifelong practice. Alongside the heavy moments, Jonathan brings humour, warmth and deep compassion, sharing how movement, group fitness, love, and chosen family helped them rebuild a life they want to stay in. This is a powerful, vulnerable and deeply human conversation about staying alive, finding joy after trauma, and learning how to come home to yourself. For information about Jonathan's upcoming Hot and Healed Tour head here. THE END BITS: Listen to more No Filter interviews here and follow us on Instagram here. Discover more Mamamia podcasts here. Feedback: podcast@mamamia.com.au Share your story, feedback, or dilemma! Send us a voice message, and one of our Podcast Producers will get back to you ASAP. Rate or review us on Apple by clicking on the three dots in the top right-hand corner, click Go To Show then scroll down to the bottom of the page, click on the stars at the bottom and write a review. We’re giving away a Your Reformer Pilates bed (worth $3,400) Subscribe to enter. CREDITS: Guest: Jonathan Van Ness Host: Naima Brown Executive Producer: Bree Player Audio Producer: Tina Matalov Video Producer: Josh Green Recorded with Session in Progress studios. Mamamia acknowledges the Traditional Owners of the Land we have recorded this podcast on, the Gadigal people of the Eora Nation. We pay our respects to their Elders past and present, and extend that respect to all Aboriginal and Torres Strait Islander cultures. Become a Mamamia subscriber: https://www.mamamia.com.au/subscribeSee omnystudio.com/listener for privacy information.

As 2026 begins, Contagion Podcast reflects on 2025, a year that tested global public health systems and reshaped how we think about infectious diseases, trust, and preparedness. In this special year in review episode, hosts Jackie Sherbuk and Vivian Vega examine the most consequential infectious disease and public health stories of the year—placing outbreaks, policy decisions, and scientific breakthroughs into clear clinical and societal context.The episode begins by confronting one of the defining challenges of 2025: erosion of public trust in public health institutions amid leadership upheaval, funding cuts, and widespread misinformation. Against this backdrop, long-controlled diseases returned with force. Measles resurged across the United States and Europe, threatening elimination status and exposing the consequences of falling vaccination coverage. Influenza surged early and intensely, straining hospitals and disproportionately impacting children and older adults. Other vaccine-preventable diseases—including pertussis and polio—reemerged, reminding listeners that immunity gaps anywhere can place everyone at risk.Beyond vaccines, the hosts explore global crises such as widespread cholera outbreaks driven by conflict, displacement, and climate-related flooding; ongoing tuberculosis transmission, including a major U.S. outbreak; and the expanding geographic reach of mosquito-borne diseases like dengue, chikungunya, and West Nile virus. They also discuss how viral hemorrhagic fever outbreaks, while limited in case numbers, continue to stress-test public health response systems worldwide.Importantly, the episode closes on hope. Breakthroughs such as twice-yearly lenacapavir for HIV prevention represent a paradigm shift in prevention and equity. Historic progress toward eliminating mother-to-child transmission of HIV, syphilis, and hepatitis B demonstrates what sustained investment and coordinated care can achieve. Above all, the hosts honor the resilience and dedication of healthcare and public-health professionals who continue to protect communities amid uncertainty.This episode offers a thoughtful, candid look at 2025—and a reminder that preparedness, communication, and trust remain our most powerful tools.Dr. Vega would like to thank her friend Job Meiller for his musical contributions, "One," and "Imagine," to our major segment breaks. Thank you, Job!Thanks also to Dr. Ana Velez, our artistic contributor, for her artwork utilized in our episode thumbnails.

TWiP solves the case about the man with positive Strongyloides serology who is waiting for a kidney transplant. Hosts: Vincent Racaniello, Daniel Griffin, and Christina Naula Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Links for this episode Join the MicrobeTV Discord server Chronic strongyloidiasis (Australian Family Physician) Hero:  Gwendoleen Rees (Wikipedia) TWiP study – information and survey Letters read on TWiP 272 New Case 40 year old man travels to India, is only there for a week before he develops problems. Bloating, diarrhea. Weathers the storm. Returns to US. Stool sent for testing. Some interesting results. Comes back positive for Hymenolepis nana, Blastocystis hominis, Giardia intestinalis. Recommended he take four tablets. Flatulence. HIV negative. He ate food that were prepared in the home but also out. Delhi area.  Become a patron of TWiP  Send your questions and comments to twip@microbe.tv Music by Ronald Jenkees Dear TWiP listeners, Have you ever wondered how TWiP shapes your understanding of science? We have! To find out more, Christina and the team are running a survey based study to learn more about how TWiP contributes to your scientific literacy and trust in science. Listen to the segment in this episode (TWiP 267) where Christina discusses the study's aims and scope.   Anyone who listens to TWiP can participate. The survey is anonymous and we do not collect personal data that could identify you. There are no potential disadvantages or harms in taking part, other than using a few minutes of your time. You will receive no direct benefit from taking part in this study. However, the information that is collected during this study will give us a better understanding of who our listeners are, and why they choose to listen to TWiP. We can use this understanding to make TWiP even better! This is an academic study and we aim to disseminate our findings to the wider public, including you. For example, we'll have a conversation about the findings on a future episode of TWiP, we plan conference presentations and publication in a relevant academic journal The project has been reviewed and approved by the University of Glasgow College of Medical, Veterinary & Life Sciences Ethics Committee. Application 200250013 You can find the study, detailed participant information, and consent information here:  TWiP study – information and survey 

The latest BARRACKS TALK podcast episode is waiting, press 'play' now!   Ever wake up on a flight to some random lady spilling her guts about donating a kidney 'cause "God whispered sweet nothings?" Dive into this chaos where the DV Radio Crew roasts the hell out of a bored-laden woman leading to organ giveaways, shady marriage vibes, and the ultimate hack... getting a punch card for future kidneys like it's a damn loyalty program. From weather woes in frozen hellholes to savage jabs at everything from HIV preps to God's got better things to do, it's that raw barracks banter that'll have you questioning life's wildest decisions while cracking up at the absurdity of it all... And trying to figure out what the fuck is going on. - Grab Your DV Radio Merch Before It Is Gone! https://bit.ly/DVR-StreamLabs-Merch - Star Spangled Brewing Co. [THE OFFICIAL BEER OF DV RADIO] https://www.starspangledbrewingco.com/ - Hard Of Hearing, Deaf, or Have Other Hearing Issues? READ THE TRANSCRIPT! https://dvradio.net/deaf-and-hard-of-hearing/ - Grab Your DV Radio Merch! https://bit.ly/DVR-SreamLabs-Merch  - Hope For 22 A Day https://hopefor22aday.org/ - Liberty Risk Podcast https://beacons.ai/libertyriskpodcast - INERT Mugs www.inertmugs.com - Laugh It Off https://www.laughitoff.org/ - Want To Sponsor DV Radio? No pricing model beats DV Radio when it comes to sponsorship. https://bit.ly/SponsorDVRadio DV Radio on Rumble https://rumble.com/c/DVRadio DV Radio on twitch.tv https://www.twitch.tv/dvradio - Burn It Down Change Unchained Tumbler from INERT Mugs Website: https://www.inertmugs.com/products/20oz-burn-it-down-thermite-tumbler [NOTE: Click these links!] ---------- DV Farm Septic System Fundraiser https://donorbox.org/dv-farm-septic-system ---------- Parental Control Apps https://bit.ly/ChildSafeInternet ---------- Backpacks For Life https://backpacksforlife.org/ ---------- Wah-Tie Woodturning https://wahtiewoodturning.com/ ---------- Backpacks For Life Fundraiser https://ko-fi.com/dvradio/goal?g=1 ---------- Edited by Munkee Bawlz Media https://www.munkeebawlzmedia.com/ ---------- Are you a Veteran Owned Business? Have unique, handmade items that we can buy and review on a show? Contact us, show us what you have, and we'll (at least Bo) will spend up to $50 per month and speak openly about your product(s)!! ---------- Find Out More About Betsy Ross At Her Website https://bit.ly/Fight-With-Betsy-Ross ---------- SGT WarDawg http://sgtwardawgtv.fans.link/ ---------- *Got an idea for BARRACKS TALK or any other show? Want to be a guest? Then please feel free to contact us by sending an email to info[at]dvradio.net or oink[at]dvradio.net.* ---------- **LINKS TO CHECK OUT** EVERYTHING DYSFUNCTIONAL VETERANS https://whereisdv.carrd.co  ---------- Grab DV Radio's Battlegrounds From Ubora Coffee At: http://bit.ly/DVR-BattlegroundCoffee  ---------- DV RADIO PARTNERS, SPONSORS, and AFFILIATES https://dvr-listen-support.carrd.co

Howie and Harlan are joined by health law and policy expert Sara Rosenbaum to discuss how incremental reform expanded healthcare access—and the urgent work now underway to prevent those gains from being undone. Harlan explores how AI is quietly filling gaps in the healthcare system; Howie highlights a milestone in the prevention of mother-to-child HIV transmission. Show notes: AI as a Healthcare Tool OpenAI: "AI as a Healthcare Ally" "Cost Leads Americans' Top-of-Mind Healthcare Concerns" "Physician sentiments around the use of AI in health care: motivations, opportunities, risks, and use cases" OpenAI: Introducing ChatGPT Health Sara Rosenbaum "The Policy Entrepreneur" KFF: Children's Health Insurance Timeline Sara Rosenbaum: "A 'Shift in Kind': A Medicaid Work Requirement Would Radically Change Health Policy" Sara Rosenbaum: "Implementing Medicaid Work Reporting Requirements: Defining A 'Serious Or Complex Medical Condition'" Sara Rosenbaum: "Who's Affected by Medicaid Work Requirements? It's Not Who You Think" "South Carolina reports 124 new measles cases as outbreak grows""Medical Groups Will Try to Block Childhood Vaccine Recommendations" CDC: About the Vaccines for Children (VFC) Program Sara Rosenbaum: "A Twenty-First Century Vaccines For Children Program" Sara Rosenbaum: "Nearly 5.6 Million Community Health Center Patients Could Lose Medicaid Coverage Under New Work Requirements, with Revenue Losses Up to $32 Billion" Sara Rosenbaum: "How Medicaid Built Community Health Centers and Health Centers Returned The Favor" KFF: 5 Key Facts About Medicaid and Provider Taxes "How New Limits on State Provider Taxes Will Affect Medicaid Funding" Preventing Mother-to-Child Infection "WHO validates Brazil for eliminating mother-to-child transmission of HIV" Health & Veritas Episode 178: Sarah DeSilvey: Creating Space for Healing "Why Syphilis Cases in Newborns Are Rising Even as STIs Decline" In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.

The CDC and ACEP both recommend opt-out screening for HIV in most emergency departments, though this practice is far from widespread. Host Peter Lorenz, MD, sits down with Emory University's Emma Sizemore, MD, MPH, to discuss the nuances of implementing an opt-out HIV and HCV screening program in the emergency department.

The biotech industry stands on the verge of a radical transformation thanks to artificial intelligence (AI) and machine learning (ML). But even the most sophisticated algorithms are only as smart as the data feeding them.David Brühlmann sits down with Troy Lionberger, Chief Business Officer at A-Alpha Bio, whose team has quietly shattered the data ceiling by measuring and curating more than 1.8 billion protein interactions. Troy Lionberger brings an insider's perspective from the frontlines of machine learning-powered drug discovery. From partnering with leading biotechs to redesigning classic antibodies for previously “impossible” targets, Troy's work pushes the edges of what's tractable in biologic therapeutics.What you'll hear in this episode:Limitations of public data sources like the Protein Data Bank and their impact on current protein engineering approaches (03:11)Why combining energetic (ΔG) and structural data matters for building predictive protein engineering models (05:43)A-Alpha Bio's approach to generating 1.8 billion protein interaction measurements for machine learning—what this enables today and what's possible next (06:30)Examples of how A-Alpha Bio's platform solves challenging therapeutic problems, such as optimizing molecules for 800+ HIV variants and engineering dual-specific antibodies (07:36)The ongoing debate: What capabilities should biotech companies keep in-house, and what works best outsourced to service providers? (09:59)The potential of synthetic epitopes as vital tools for training models beyond the Protein Data Bank—introducing the Synthetic Epitope Atlas (12:09)Key takeaways for scientists: the importance of diligence amidst rapidly evolving AI claims, and advice for accelerating R&D with the right data (14:57)Wondering how to move protein therapeutics from “interesting” to “impactful” without waiting for years of crystal structures? Listen in to learn how you can harness next-gen machine learning tools and custom datasets for your development projects.Connect with Troy Lionberger:LinkedIn: www.linkedin.com/in/troylionbergerA-Alpha Bio website: www.aalphabio.comNext step:Need fast CMC guidance? → Get rapid CMC decision support hereSupport the show

Tune in as Princy N. Kumar, MD, MACP, FRCP, and Charlotte-Paige Rolle, MD, MPH discuss the latest in immune recovery, chronic inflammation, and more in the management of treatment-experienced people living with HIV.Topics covered include:Immunologic nonresponseTheories around soluble gp120 and antibody-dependent cellular cytotoxicityLatest data from BRIGHTE, RECOVER, and moreFuture DirectionsPresenters:Princy N. Kumar, MD, MACP, FRCPProfessor of Medicine and MicrobiologyChief, Division of Infectious Diseases and Tropical MedicineVice Dean for Student AffairsGeorgetown University School of MedicineWashington, DCCharlotte-Paige Rolle, MD, MPHDirector of Research OperationsOrlando Immunology CenterAdjunct Assistant Professor of Global HealthEmory University Rollins School of Public HealthAtlanta, GeorgiaLink to full program: https://bit.ly/4pEenZCGet access to all of our new podcasts by subscribing on Apple Podcasts, Google Podcasts, or Spotify! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Daniel Garza had momentum. Acting roles, directing gigs, national tours lined up. Then anal cancer stopped everything. Radiation wrecked his body, stripped him of control, and left him in diapers, staring down despair. His partner, Christian Ramirez, carried him through the darkest nights, changed his wounds, fought hospitals, and paid the price with his own health. Christian still lives with permanent damage from caregiving, but he stayed anyway.Together they talk with me about masculinity, sex, shame, friendship, and survival. They describe the friendships that vanished, the laughter that kept them alive, and the brutal reality of caregiving no one prepares you for. We get into survivor guilt, PTSD, and why even rocks need rocks. Daniel is now an actor, director, and comedian living with HIV. Christian continues to tell the unfiltered truth about what it takes to be a caregiver and stay whole. This episode gives voice to both sides of the cancer experience, the survivor and the one who stands guard. RELATED LINKSDaniel Garza IMDbDaniel Garza on InstagramDaniel Garza on FacebookChristian Ramirez on LinkedInLilmesican Productions Inc (Daniel & Christian)Stupid Cancer FEEDBACKLike this episode? Rate and review Walk It Off on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In episode 65 of Going anti-Viral, Dr Gerald Friedland joins host Dr Michael Saag as the recipient of the IAS–USA Lifetime of Leadership Award, established nearly 15 years ago to honor individuals whose contributions have left a profound and lasting impact on HIV medicine, scientific education, and the mission of the IAS–USA. Dr Friedland discusses his extensive journey in the field of HIV/AIDS and infectious diseases, reflecting on his early career, the challenges faced during the early years of the AIDS epidemic, and the evolution of treatment strategies. Dr Friedland and Dr Saag emphasize the importance of collaboration, compassion, and the pursuit of knowledge in addressing public health crises. Dr Friedland also discusses his research on tuberculosis and the integration of HIV treatment, highlighting important findings that have impacted healthcare practices.0:00 – Introduction 3:03 – Early life and medical journey5:43 – First encounters with HIV/AIDS8:39 – Understanding transmission and stigma11:22 – Coping with the AIDS crisis14:53 – The AZT trials and early treatments16:31 – Advancements in HIV treatment19:30 – Research on tuberculosis and HIV27:32 – Reflections on a lifelong careerResourcesIn-person or virtual registration for the presentation of the IAS-USA Lifetime of Leadership Award at the Scott M. Hammer Annual Update on HIV Management in New York, New York on March 16, 2026: https://www.iasusa.org/events/hiv-update-2026-new-york/__________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

From the HIV wards of New York City in the 1980s to leadership roles in Uganda during the scale-up of antiretroviral therapy through PEPFAR, Dr. Yukari Manabe has seen major transformations in infectious disease diagnostics, treatment and care. In this episode, she talks about her journey in medicine and global health and why her work in building local capacity in the Global South may be her most important legacy of all. She is the Associate Director of Global Health Research and Innovation at Johns Hopkins University.

Confira os destaques do Jornal da Manhã desta terça-feira (13): Os Estados Unidos emitiram nesta segunda-feira (12) um alerta oficial recomendando que cidadãos americanos deixem o Irã imediatamente, diante da intensificação dos protestos contra o regime e do agravamento do cenário de segurança. O Tribunal de Contas da União (TCU) e o Banco Central adotaram um tom mais cauteloso diante da polêmica envolvendo o Banco Master, sinalizando que qualquer indenização a investidores só será avaliada após a conclusão de uma inspeção técnica. A apuração, que deve durar cerca de um mês, busca esclarecer a real situação da instituição antes de decisões definitivas. Denise Campos de Toledo analisou. A presidente do México, Claudia Sheinbaum, afirmou em conversa telefônica com o presidente dos Estados Unidos, Donald Trump, que a presença de tropas americanas em território mexicano “não está em discussão”. O posicionamento ocorre após Trump ameaçar uma possível intervenção militar para combater cartéis de drogas no México. A defesa do ex-presidente Jair Bolsonaro apresentou um novo recurso ao Supremo Tribunal Federal contra a condenação de 27 anos e três meses de prisão por envolvimento na chamada trama golpista. No agravo regimental enviado ao ministro Alexandre de Moraes, os advogados pedem a reconsideração da decisão que rejeitou recursos anteriores ou, caso isso não ocorra, que o caso seja analisado pelo plenário da Corte. A Anvisa aprovou o uso do lenacapivir injetável como nova opção de profilaxia pré-exposição (PrEP) contra o HIV no Brasil. O medicamento, de longa duração, surge como alternativa às pílulas orais e é indicado para adultos e adolescentes a partir de 12 anos, com pelo menos 35 kg, que estejam em risco de infecção. Para iniciar o uso, é obrigatório testar negativo para o vírus. A Polícia Federal deflagrou nesta terça-feira (13) uma nova fase da Operação Overclean, que tem como alvo o deputado federal Félix Mendonça Jr. (PDT-BA). A investigação, realizada com apoio da CGU e da Receita Federal, apura a atuação de uma organização criminosa suspeita de desviar emendas parlamentares, além de práticas de corrupção e lavagem de dinheiro. O presidente da Câmara dos Deputados, Hugo Motta (Republicanos-PB), afirmou que aguarda um gesto do presidente Luiz Inácio Lula da Silva para definir seu apoio na disputa ao Planalto. Em entrevista, Motta destacou que a política é baseada em reciprocidade. O governo da Groenlândia afirmou nesta segunda-feira (12) que não aceitará, sob nenhuma circunstância, qualquer tentativa dos Estados Unidos de se apoderarem do território. Diante do aumento das tensões geopolíticas no Ártico, as autoridades locais anunciaram que irão intensificar os esforços diplomáticos e militares para garantir a defesa da ilha por meio da Otan. Uma autoridade do governo do Irã afirmou à agência Reuters que cerca de 2 mil pessoas, incluindo integrantes das forças de segurança, morreram em apenas duas semanas de protestos no país. A declaração marca a primeira vez que representantes ligados ao regime dos aiatolás reconhecem publicamente a dimensão das mortes causadas pela repressão às manifestações. Essas e outras notícias você acompanha no Jornal da Manhã. Learn more about your ad choices. Visit megaphone.fm/adchoices

Broadcast from KSQD, Santa Cruz on 1-01-2025: An emailer asks about omega-3 supplementation for memory at age 72. Dr. Dawn advises checking that fish oil capsules contain adequate DHA—at least 1,000 mg—since many omega-3 products have low DHA levels. She notes Medicare covers the same testing at standard labs as proprietary labs like OmegaQuant that charge patients directly. Beyond omega-3s, she emphasizes glucose control (hemoglobin A1c below 5.6) since the enzyme that breaks down insulin also clears beta-amyloid, and weight training to raise brain-derived neurotrophic factor (BDNF), which promotes new synapse formation essential for memory. Dr. Dawn reviews Popular Science's top 2025 health innovation: eye drops from Lens Therapeutics containing aceclidine that correct age-related farsightedness for 10 hours. The drops shrink the pupil to increase depth of field, improving near vision by three or more lines on eye charts within 30 minutes without affecting distance vision. Side effects include eye irritation, dimmed night vision, and headache. She describes Duke University's breakthrough allowing heart transplants from circulatory death donors using an on-table reanimation technique. This could expand the pediatric donor pool by 20%—critical since up to 20% of children die waiting for transplants. Dr. Dawn celebrates CAR-T immunotherapy for multiple myeloma, which saved her husband's life. Of 97 heavily pretreated patients, 38% achieved complete remission still present at five years, with over 50% total survival. The therapy removes T-cells, uses CRISPR to add receptors targeting cancer cell antigens, then reinfuses the modified cells. She highlights a UC Davis study showing remote blood pressure monitoring with home technology, education, and coaching dropped patients' average blood pressure from 150/80 to 125/74 in months—low-tech with high impact. Dr. Dawn explains the Nano Knife for prostate cancer, which uses localized electrical pulses delivered through thin wires to destroy tumors while sparing surrounding nerves. This minimally invasive approach could reduce erectile dysfunction and incontinence common with traditional surgery. She describes Gilead's Sunlenca, a twice-yearly injection for HIV prevention that's 99% effective. At $14,000 per injection in the US, proceeds help fund access in resource-limited countries where it can be distributed like a vaccination. Dr. Dawn discusses Journavx (suzetrigine), a new non-opioid pain medication working on sodium channels to block pain signals before reaching the brain. At $30 for 50 pills on GoodRx, it offers an alternative for surgical pain in patients with addiction history or genetic vulnerability to opioid dependence. She details the landmark case of Baby KJ, the first person to receive personalized CRISPR gene therapy. Born with a CPS1 enzyme deficiency causing toxic ammonia buildup, KJ was too small for liver transplant. Scientists identified his specific mutation and used CRISPR base editing delivered via lipid nanoparticles to correct a single DNA letter—changing an A to G—in his liver cells which restored enough function to be discharged home. Dr. Dawn reports surprising findings that COVID mRNA vaccines amplify cancer immunotherapy. Lung cancer patients who received COVID vaccination within 100 days of checkpoint inhibitor treatment had 56% three-year survival versus 31% for unvaccinated patients. The mechanism is unknown but may involve mRNA generally alerting the immune system. She revisits research showing Zostavax shingles vaccination reduced dementia risk by 20% over seven years. A natural experiment in Wales—where an age cutoff created comparable vaccinated and unvaccinated groups—provided strong evidence that preventing herpes zoster inflammation protects brain health. Dr. Dawn concludes with Huntington's disease breakthrough: microRNA therapy delivered by virus directly into the brain slowed disease progression by 75% over three years. The microRNA binds to Huntington protein mRNA, preventing ribosome translation and toxic protein production. Some patients returned to work; others expected to need wheelchairs are still walking.

NECA in the Know kicks off the new year with a conversation about long-acting PrEP. Tune in to hear Marianna's chat with John Faragon about a once-monthly PrEP option. They talk all about advantages, disadvantages, studies, and more. -- Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=AQX7941)--Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes. --Check out our free online courses: www.necaaetc.org/rise-courses--Download our HIV mobile apps:Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=USApple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

Send us a textThe average primary care visit lasts about 18 minutes. Complex symptoms, multiple conditions, and a maze of electronic forms don't fit neatly into that window—and neither do the emotions that come with being sick. We sat down with advocates including a medical writer who was part of ACT UP, a sickle cell advocacy leader and a humanities scholar turned epidemiologist to unpack how patients, families, and clinicians can turn limited time into better outcomes with clearer language, smarter tools, and community trust.We dig into the numbers behind health literacy and why discharge summaries so often miss the mark, then translate that research into steps anyone can use: keep a simple medication list, coordinate records across specialists, and lean on reliable sources like local health departments and major nonprofits. Faith Adjei-Sarpong shares how sickle cell stigma—especially around pain and opioids—creates dangerous delays in care, and how sharing real stories online and off can shift bias. Drs. Heather Duncan and Patrick Murphy explain how plain-language micro-learning helps both sides of the exam room, and how medical writers can bridge patients and providers without diluting the science.We also surface the trust problem. The wellness industry wins attention with community and clear words, even when products are unregulated. So we talk about meeting people where trust already lives—barber shops, neighborhood centers—and why that approach worked from HIV activism to recent Mpox vaccination drives. Along the way, we address clinician burnout, the pressure of quotas, and the case for labor power in medicine to protect both providers and patients.If you care about health equity, patient rights, and practical advocacy, this conversation gives you a roadmap: listen first, use plain language, build locally, and measure success by human impact. Subscribe, share with a friend who needs it, and tell us what you think!Fact-check note: The pharmaceutical industry is currently valued around $1 trillion, but it is expected to exceed $3 trillion after 2030.Thanks for listening to the Infectious Science Podcast. Be sure to visit infectiousscience.org to join the conversation, access the show notes, and don't forget to sign up for our newsletter to receive our free materials. We hope you enjoyed this new episode of Infectious Science, and if you did, please leave us a review on Apple Podcasts and Spotify. Please share this episode with others who may be interested in this topic! Also, please don't hesitate to ask questions or tell us which topics you want us to cover in future episodes. To get in touch, drop us a line in the comment section or send us a message on social media. Instagram @InfectscipodFacebook Infectious Science PodcastSee you next time for a new episode!

Episode Summary In this special feed drop episode, Please Me host Eve Hall shares a powerful conversation from the Shameless Care Podcast, exploring the history of HIV and AIDS—from its devastating beginnings to today's life-saving medical breakthroughs. This episode traces how fear, misinformation, and stigma shaped the early AIDS crisis, how science and activism transformed treatment, and where we stand now with modern prevention tools like antiretroviral therapy (ART) and PrEP. It's a vital conversation about education, access, consent, and the importance of shame-free sexual health care. The first reported HIV/AIDS cases in the early 1980s Early misconceptions, panic, and stigma surrounding transmission The discovery of HIV and the development of testing Why AIDS was once considered universally fatal The role of public health leaders, including Dr. Anthony Fauci Activism, government response, and public education efforts Breakthroughs in HIV treatment and combination therapy (HAART) The meaning of Undetectable = Untransmittable (U=U) How PrEP has transformed HIV prevention Why HIV still affects communities today due to gaps in access and awareness  Connect With the Hosts Website: https://shamelesscare.com Podcast: Shameless Care Podcast Connect With Eve  Website: https://pleaseme.online Social Media & Contact: https://pleaseme.online/contacts Substack Newsletter: https://pleaseme.substack.com Patreon (Ad-Free & Bonus Content): https://patreon.com/PleaseMePodcast Be a Guest: Apply via PodMatch https://www.podmatch.com/hostdetailpreview/beaguestonpleasemepodcast Learn more about your ad choices. Visit megaphone.fm/adchoices

Kgomotso Modise, in for Clement Manyathela speaks to Nozibele Mayaba, HIV activist, podcaster, speaker and author, reflecting on her journey and her newly launched book 'Let me tell you something'. Tags: Clement Manyathela Show, Kgomotso Modise, Nozibele Mayaba, HIV activist, podcaster, speaker and author, 'Let me tell you something' The Clement Manyathela Show is broadcast on 702, a Johannesburg based talk radio station, weekdays from 09:00 to 12:00 (SA Time). Clement Manyathela starts his show each weekday on 702 at 9 am taking your calls and voice notes on his Open Line. In the second hour of his show, he unpacks, explains, and makes sense of the news of the day. Clement has several features in his third hour from 11 am that provide you with information to help and guide you through your daily life. As your morning friend, he tackles the serious as well as the light-hearted, on your behalf. Thank you for listening to a podcast from The Clement Manyathela Show. Listen live on Primedia+ weekdays from 09:00 and 12:00 (SA Time) to The Clement Manyathela Show broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/XijPLtJ or find all the catch-up podcasts here https://buff.ly/p0gWuPE Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

Lawrence Blatt, Chairman, President, and CEO of Aligos Therapeutics,  describes the current gaps in treating the hepatitis B virus and how the disease can potentially lead to end-stage liver disease and liver cancer. Current therapies were initially developed for HIV and can suppress the virus but not eliminate or prevent the disease. The lead Aligos drug candidate blocks all steps of viral replication and prevents the virus from integrating into infected liver cells, where it can activate cancer-causing genes. Lawrence explains, "Hepatitis B virus is actually the most prevalent chronic viral infection in the world that makes patients very ill, and they can actually die from this disease. There's almost 250 million, a little bit more than 250 million people infected with Hepatitis B. And it really affects people in all walks of life across many different demographic groups. So there's not a typical HPV patient out there."   "So HBV needs to be treated for life, currently very similar to HIV, and actually HBV and HIV share common features. And early on in the HIV epidemic, patients who were treated with a class of drug called nucleoside analogs, who were also coinfected with HBV, we saw responses to those drugs. So the drugs that worked in HIV, called nucleoside or nucleotide analogs that were purposely built for HIV, worked against HBV, and they worked to a certain degree. They can suppress the virus, but they can't eliminate the virus, and they can't completely suppress all the components of the viral lifecycle that end up causing disease."   "So we're not going to affect the damage that's there initially, but we're blocking that damage from occurring. Now, one thing that's really interesting is that our livers are regenerative organs. So the liver is constantly replacing itself with new healthy hepatocytes or cells that make up the liver. And so if you could block the ongoing disease processes, the liver will have time to heal itself and eventually reverse the scarring. And that's really the only organ in our body that can regenerate. If you get scarring on your lungs or any other part of your body, that is for life. But in the liver, if you block the disease processes, you can reverse that scarring. So it's a very important and unique finding."  #AligosTherapeutics #HepatitisB #Biotechnology #DrugDevelopment #LiverHealth #ClinicalTrials #MedicalBreakthrough #PatientCare #Virology #PharmaceuticalInnovation #Vaccines Aligos.com Download the transcript here  

Lawrence Blatt, Chairman, President, and CEO of Aligos Therapeutics,  describes the current gaps in treating the hepatitis B virus and how the disease can potentially lead to end-stage liver disease and liver cancer. Current therapies were initially developed for HIV and can suppress the virus but not eliminate or prevent the disease. The lead Aligos drug candidate blocks all steps of viral replication and prevents the virus from integrating into infected liver cells, where it can activate cancer-causing genes. Lawrence explains, "Hepatitis B virus is actually the most prevalent chronic viral infection in the world that makes patients very ill, and they can actually die from this disease. There's almost 250 million, a little bit more than 250 million people infected with Hepatitis B. And it really affects people in all walks of life across many different demographic groups. So there's not a typical HPV patient out there."   "So HBV needs to be treated for life, currently very similar to HIV, and actually HBV and HIV share common features. And early on in the HIV epidemic, patients who were treated with a class of drug called nucleoside analogs, who were also coinfected with HBV, we saw responses to those drugs. So the drugs that worked in HIV, called nucleoside or nucleotide analogs that were purposely built for HIV, worked against HBV, and they worked to a certain degree. They can suppress the virus, but they can't eliminate the virus, and they can't completely suppress all the components of the viral lifecycle that end up causing disease."   "So we're not going to affect the damage that's there initially, but we're blocking that damage from occurring. Now, one thing that's really interesting is that our livers are regenerative organs. So the liver is constantly replacing itself with new healthy hepatocytes or cells that make up the liver. And so if you could block the ongoing disease processes, the liver will have time to heal itself and eventually reverse the scarring. And that's really the only organ in our body that can regenerate. If you get scarring on your lungs or any other part of your body, that is for life. But in the liver, if you block the disease processes, you can reverse that scarring. So it's a very important and unique finding."  #AligosTherapeutics #HepatitisB #Biotechnology #DrugDevelopment #LiverHealth #ClinicalTrials #MedicalBreakthrough #PatientCare #Virology #PharmaceuticalInnovation #Vaccines Aligos.com Listen to the podcast here  

David Dodd, CEO of GeoVax,  highlights the need for next-generation vaccines, specifically multi-antigen and T cell-focused technologies, to provide better protection for immunocompromised populations. Their pipeline includes a COVID-19 vaccine candidate, an Mpox/Smallpox vaccine, and a gene therapy for solid tumors. A priority for GeoVax is to develop new manufacturing processes to significantly accelerate vaccine production, increase yield, and reduce costs. David explains, "Multi-antigen vaccines become critically important, especially for populations for whom the existing approach in vaccines, meaning single-antigen vaccines or antibody-focused or antibody-only vaccines, is inadequate. And to clarify that, there are approximately 40 million adults in the United States, about 10 times that number worldwide, who suffer from various medical conditions, such as blood cancers. They may have renal disease, diabetes, or be HIV positive. They may also have weakened immune systems, they could have multiple sclerosis or lupus. So there are a host of medical conditions that the result is they inhibit or they deplete an individual's immune system from mounting an adequate antibody response. And keep in mind, the antibody system is that first line of defense when an infectious threat occurs. And that's sort of like the frontline soldiers. They throw up a protective guard to respond to that." "That means for those individuals, what we need to do is also address this, as we develop vaccines, and some technologies allow you to do this. The majority of vaccine platforms do not, unfortunately. And that is to also induce a very strong cellular immunity or T cells. And this becomes critically important because T cells are what clear a virus from the body. It's also what drives what is known as memory, and also gives breadth or robustness of protection. So it becomes critically important that if one has the opportunity because of their technology or the platform they're utilizing to enlist and engage both the antibody as well as the cellular side, then one can generally develop a much more robust protective immune response that will reduce the risk of severe infection, hospitalization, and the risk of death against certain infections." #GeoVax #Biotech #Vaccines #PublicHealth #Healthcare #COVID19 #LifeSciences #Biotechnology #Mpox #GlobalHealth  geovax.com Listen to the podcast here

David Dodd, CEO of GeoVax,  highlights the need for next-generation vaccines, specifically multi-antigen and T cell-focused technologies, to provide better protection for immunocompromised populations. Their pipeline includes a COVID-19 vaccine candidate, an Mpox/Smallpox vaccine, and a gene therapy for solid tumors. A priority for GeoVax is to develop new manufacturing processes to significantly accelerate vaccine production, increase yield, and reduce costs. David explains, "Multi-antigen vaccines become critically important, especially for populations for whom the existing approach in vaccines, meaning single-antigen vaccines or antibody-focused or antibody-only vaccines, is inadequate. And to clarify that, there are approximately 40 million adults in the United States, about 10 times that number worldwide, who suffer from various medical conditions, such as blood cancers. They may have renal disease, diabetes, or be HIV positive. They may also have weakened immune systems, they could have multiple sclerosis or lupus. So there are a host of medical conditions that the result is they inhibit or they deplete an individual's immune system from mounting an adequate antibody response. And keep in mind, the antibody system is that first line of defense when an infectious threat occurs. And that's sort of like the frontline soldiers. They throw up a protective guard to respond to that." "That means for those individuals, what we need to do is also address this, as we develop vaccines, and some technologies allow you to do this. The majority of vaccine platforms do not, unfortunately. And that is to also induce a very strong cellular immunity or T cells. And this becomes critically important because T cells are what clear a virus from the body. It's also what drives what is known as memory, and also gives breadth or robustness of protection. So it becomes critically important that if one has the opportunity because of their technology or the platform they're utilizing to enlist and engage both the antibody as well as the cellular side, then one can generally develop a much more robust protective immune response that will reduce the risk of severe infection, hospitalization, and the risk of death against certain infections." #GeoVax #Biotech #Vaccines #PublicHealth #Healthcare #COVID19 #LifeSciences #Biotechnology #Mpox #GlobalHealth  geovax.com Download the transcript here

Gen Z men are moving away from MAGA in droves, polls show | The Independent The Worst Thing About Elon Musk Is That He Got Away With All of It | The New Republic Could the feds throw you in jail for merely filming ICE immigration raids? An HIV expert at the CDC was asked to scrub data on trans people. He quit instead. - LGBTQ Nation Congress looks to reclaim relevance after ceding power to White House Trump sent Mar-a-Lago masseuses on Epstein house calls: report - Salon.com

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com Accessible diagnostics isn't a luxury anymore; it's the missing link preventing millions from receiving timely care. In this episode, James York, Chief Commercial Officer and Head of Government Affairs for Molecular Testing Labs, discusses how reimagining the patient journey can remove the economic, geographic, and emotional barriers that keep people from getting essential tests. He explains how at-home self-collection, transparent pricing, and frictionless access are transforming diagnostics, especially for conditions like HIV, STIs, chronic disease markers, and wellness indicators. James walks through the challenges of pioneering new models in healthcare, including regulatory hurdles, industry resistance, and the realities of scaling without major outside funding. He also explains why affordability is inseparable from access, how virtual care has shifted expectations, and why focusing on everyday tests, not cutting-edge technology, is where the greatest impact lies. Tune in and learn how simplifying diagnostics can unlock a more equitable, consumer-centered healthcare system! Resources Connect with and follow James York on LinkedIn. Follow Molecular Testing Labs on LinkedIn and visit their website!

Opposition seeks removal of Czech lower house speaker after controversial speech, Czech scientist named among Time's 100 Most Influential People for HIV breakthrough, Czech juniors to play for gold at World Championships after defeating Canada 6:4 in shootout, Czech Academy of Sciences launches a digital archive of 15,000 folk songs

RaeAnn Tucker joined Wake Up Tri-Counties to talk about resolutions, reproductive health, HIV prevention, insurance navigators, flu and COVID-19 vaccines, and gun locks. The Henry and Stark County Health Departments are doubling down on their commitment to community wellness in 2026 with a range of initiatives. Residents can access free and confidential HIV prevention services, including testing, education, and medication support through the PrEP/HIV Prevention program at First Choice Healthcare Clinics in Kewanee and Toulon. In a push for safety, free gun locks aimed at preventing firearm injuries are available weekdays at multiple locations. For those navigating health insurance, the Get Covered Illinois Navigator Program offers personalized assistance at upcoming local events. Visit henrystarkhealth.com or follow their social media for updates and resources.

Bird-flu, bombs and asteroids: are we heading for disaster in 2026? What are the biggest threats to global health security in 2026? Is it bird flu? Or the rising threat posed by nuclear weapons? Could we even be hit by an asteroid?Dr Becky Alexis-Martin, a Lecturer in Peace Studies at the University of Bradford and an expert on nuclear weapons, argues that the threat they pose will continue to rise in the new year.Paul Nuki, the Telegraph's Global Health Security Editor, warns that numerous diseases linked to conflict are likely to continue to spread in 2026 – in particular cholera and HIV.Meanwhile, the possibility of H5N1 bird flu making the jump to humans and causing a pandemic remains a primary threat, as does the continued spread of mpox around the world.Lord Martin Rees, the former Astronomer Royal and a founder of the Centre for the Study of Existential Risk, assesses the risk of space-based threats.Producer: Sophie O'SullivanExecutive Producer: Louisa WellsStudio Operator: Meghan Searle► Sign up to our most popular newsletter, From the Editor. Look forward to receiving free-thinking comment and the day's biggest stories, every morning. telegraph.co.uk/fromtheeditorContact us with feedback or ideas:battlelines@telegraph.co.uk @venetiarainey Hosted on Acast. See acast.com/privacy for more information.

Omari Richins, MPH of Public Health Careers podcast discusses the significant public health victories of 2025, highlighting the resilience and innovation of health professionals worldwide. Despite challenges like funding cuts and public skepticism, breakthroughs emerged, including the world's first pandemic agreement, advancements in HIV prevention, and new treatments for malaria and tuberculosis. These achievements underscore the importance of collaboration and innovation in public health.

In this powerful conversation, I'm joined by Dr. Chad Zawitz, a physician who spent over two decades delivering frontline medical care inside one of the largest urban jail systems in the country. Dr. Zawitz pulls back the curtain on carceral healthcare, explaining the critical differences between jail and prison, the constitutional right to medical care for incarcerated individuals, and why many patients actually experience better measurable health outcomes while locked up.We spend significant time unpacking the evolution of HIV treatment, from the early days of fear and stigma to today's extraordinary advances, including long-acting injectable antivirals and the game-changing reality that people with undetectable viral loads cannot transmit HIV. Dr. Zawitz explains why, with proper access and adherence, HIV could be effectively eliminated within a single generation, without a cure or vaccine.This episode also explores stigma, language, trauma, addiction, and the power of treating people like human beings. From stories inside the jail to reflections on COVID, public health messaging, and medical ethics, this conversation is a reminder that healing doesn't begin with protocols, it begins with compassion. Episode Highlights[00:00] – Why HIV could be eliminated in one generation with the tools we already have[03:15] – Dr. Zawitz's path into correctional healthcare and why it matters[05:40] – Jail vs. prison: understanding the difference and why it impacts care[10:30] – The constitutional right to healthcare for incarcerated individuals[14:50] – How HIV care is delivered behind bars[18:30] – The evolution of HIV treatment: from AZT to modern long-acting injectables[22:55] – U = U explained: undetectable equals untransmittable[26:30] – The role of stigma, language, and bias in healthcare outcomes[35:55] – Treating patients as people: why simple kindness changes everything[43:00] – Why health markers often improve during incarceration[48:40] – COVID in jails: fear, access, vaccines, and media narratives[55:35] – “Tales from the jail”: surprising clinical lessons from real life[01:08:50] – Public health, vaccines, and the cost of polarization[01:17:45] – Lessons from Dallas Buyers Club and early HIV innovation Links & ResourcesSilver Biotics: bit.ly/3JnxyDD— 30% off with Code: BEAUTIFULLYBROKENLightPathLED: https://lightpathled.pxf.io/c/3438432/2059835/25794— Code: beautifullybrokenCathcBio https://www.catchbio.com/beautifullybroken— Code: beautifullybrokenStemRegn: https://www.stemregen.co/products/release?_ef_transaction_id=&affid=52&oid=1Beam Minerals: http://beamminerals.com/beautifullybroken— Code: BEAUTIFULLYBROKEN  CONNECT WITH FREDDIEWork with Me: https://www.beautifullybroken.world/biological-blueprintWebsite and Store: (http://www.beautifullybroken.world) Instagram: (https://www.instagram.com/beautifullybroken.world/) YouTube: https://www.youtube.com/@freddiekimmel Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This is a free preview of a paid episode. To hear more, visit andrewsullivan.substack.comArthur is an academic and writer. The former president of the American Enterprise Institute, he's a professor at Harvard Business School and the Kennedy School, where he teaches courses on leadership and happiness. The author of 13 books — including the 2023 bestseller he co-authored with Oprah Winfrey: Build the Life You Want — his latest is The Happiness Files, a curated collection from his “How to Build a Life” column at The Atlantic. He's also the host of the “How to Build a Happy Life” podcast.An auto-transcript is available above (just click “Transcript” while logged into Substack). For two clips of our convo — how to prevent Trump from wrecking your mood, and how to open up your right brain — head to our YouTube page.Other topics: raised in Seattle by an artist mom and mathematician dad; converting to Catholicism as a teen; his early career as a French horn player; meeting his Spanish wife at a young age — and not speaking the same language; the risks that immigrants take; the British aversion to striving; walking the Camino de Santiago; his mother's struggle with depression her whole life; how half of your happiness level is genetic; Charles Murray on religion; near-death experiences; Burke; Emerson; Oakeshott; animal impulse vs moral aspiration; Nicomachean Ethics; success as a false siren; Spinoza; our obsession with screens; the AI explosion; time management; the Daily Dish and my burnout in 2015; silent meditation retreats; the happiness of having a dog; Arthur's work with the Dalai Lama; Buddhist vs Christian suffering; my deepest fear; my HIV test; the importance of failure for strivers; Stoicism; psychedelics; the Sabbath; the denialism over death; and how change is the only thing we can count on.Browse the Dishcast archive for an episode you might enjoy. Coming up: Laura Field on the intellectuals of Trumpism, Vivek Ramaswamy on the right's future, Jason Willick on trade and conservatism, and Claire Berlinski on America's retreat from global hegemony. Please send any guest recs, dissents, and other comments to dish@andrewsullivan.com.

The UK becomes the first nation to open up every single role in their Armed Forces to people living with HIV. Portland has a woke Christmas tree lighting where they refused to mention the word Christmas and spout pro-Hamas chants. A comet has a strange ‘heartbeat'-like pulse that could point to alien technology. Prince Harry goes on Stephen Colbert and receives boo's for making a bad joke about President Trump. Somali Warlord, Abdullahi Ali, allegedly received tens of MILLIONS of dollars from Maine's Medicaid program.Actress Halle Berry takes a shot at Gavin Newsom saying “he probably should not be our next president”.- Rep. Sheila Cherfilus-McCormick, who was just indicted for allegedly stealing $5M in FEMA funds, suggests she is being targeted because she is black. The first-ever “Miss Palestine” in this year's Miss Universe pageant has a connection to a convicted terrorist leader. Transportation Sec. Sean Duffy encourages everyone to dress better at the airport and “try not to wear slippers and pajamas”. A biological man is crowned the 'World's Strongest Woman', spurring rightful Internet outrage. Dem Rep. Brad Sherman gets caught watching pornography on a flight. Illinois makes an illegal alien a police officer and gives him a gun. A transgender swimmer was banned for 5 years after gender test refusal and blamed insurance costs. An illegal alien who rammed federal agents was HONORED and presented with framed accolades by LA for targeting ICE.Thank you for supporting our sponsors that make The Dana Show possible…Patriot Mobilehttps://PatriotMobile.com/Dana  OR CALL 972-PATRIOTWhat are you waiting for? Switch today during the Red, White, and Blue sale. Use promo code DANA for a Samsung A16 5g smartphone.  Sale ends soon.Relief Factorhttps://ReliefFactor.com OR CALL 1-800-4-RELIEFDon't let pain stop you from living the life you want with Relief Factor. Get their 3-week Relief Factor Quick Start for only $19.95 today! PreBornhttps://Preborn.com/DANAYou have the power to help save a life. Donate today by dialing #250 and say “Baby,” or give securely online. Make your end of year gift today.Subscribe today and stay in the loop on all things news with The Dana Show. Follow us here for more daily clips, updates, and commentary:YoutubeFacebookInstagramXMore Info

This is a re-release celebrating a decade of love and allyship on A Gay And A NonGay. This week we're throwing it back to May 2020... We've heard about 'expendable' populations before, but last time they meant gay people. 32 million people have died of AIDS related illnesses since the 1980s and in 2018, 770,000 people died worldwide because of the virus. The London Patient: A Cure For HIV? is the first episode in a brand new two-part series - funded by the Wellcome Trust and the British Podcast Awards Fund. Both episodes were recorded in accordance with government social distancing measures. On this episode, we look at the start of the epidemic, chat to AIDS activist Sir Nick Partridge OBE and head to Oxford to meet Professor John Frater who explains the science behind HIV. Trigger warning: Contains upsetting audio. Incredible advances in medicine now mean that if you are HIV+ and on effective treatment, you can't pass it on. Undetectable = Untransmittable. And in March 2019, it was revealed that a second person had been cured of HIV - The London Patient. What does the London Patient's story tell us about a cure for HIV? Plus in the age of Covid19, can the story of HIV and AIDS offer the world any hope? This episode is bought to you with thanks to the ⁠MTV Staying Alive Foundation⁠, the ⁠Terrence Higgins Trust⁠ and the ⁠National AIDS Trust⁠. Follow A Gay & A NonGay TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@gaynongay⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@gaynongay⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@gaynongay⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@gaynongay⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠gaynongay.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email Us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠us@gaynongay.com⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

In part two of our two-part series, I show Sarah a more radical side of the American Mall Santa. I tell her stories of how, in some cases, the character transformed into a symbol of societal change and guerrilla protest, from the ladies who had to take his bearded place during WWII, to the Black Santa revolutionaries of the Civil Rights Movement, to the activist Gay Santas who fought, quite creatively, against the stigma of HIV. Become a Patron⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to support our show and get early ad-free episodes and bonus content Or subscribe to American Hysteria on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get some of our new merch at ⁠⁠⁠⁠⁠⁠⁠americanhysteria.com⁠⁠⁠⁠⁠⁠⁠, all profits go to The Sameer Project, a Palestinian-led mutual aid group who are on the ground in Gaza delivering food and supplies to displaced families. Leave us a message on the ⁠⁠⁠⁠⁠⁠⁠⁠⁠Urban Legends Hotline⁠⁠⁠⁠⁠⁠⁠⁠⁠ Producer and Editor: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Miranda Zickler⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Associate Producer: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Riley Swedelius-Smith⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Additional editing by ⁠Kaylee Jasperson⁠ Hosted by Chelsey Weber-Smith Learn more about your ad choices. Visit megaphone.fm/adchoices